ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "HLA antibodies"

  • 2016 American Transplant Congress

    Preformed Antibodies Against AT1R and EDNRA Correlate with Rejection Post-Transplant.

    A. Gareau,1 C. Wiebe,1,2 D. Pochinco,2 I. Gibson,3 D. Rush,1 P. Nickerson.1,2,4

    1Internal Medicine, University of Manitoba, Winnipeg, MB, Canada; 2Diagnostic Services of Manitoba, Winnipeg, MB, Canada; 3Pathology, University of Manitoba, Winnipeg, MB, Canada; 4Immunology, University of Manitoba, Winnipeg, MB, Canada.

    Studies have investigated the potential pathogenic effects of non-HLA antibodies (Ab), with a few reporting that Ab against the angiotensin II type 1 receptor (AT1R)…
  • 2016 American Transplant Congress

    Diffuse Extent of Peritubular Capillaritis in Late Antibody Mediated Rejection Is Associated with More Severe Chronic Allograft Damage.

    Z. Kikić,1 F. Eskandary,1 H. Herkner,2 R. Oberbauer,1 G. Bond,1 H. Regele,3 G. Böhmig,1 N. Kozakowski.3

    1Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria; 2Emergency Medicine, Medical University of Vienna, Vienna, Austria; 3Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria.

    Peritubular capillaritis (ptc) is a widely accepted histologic criterion of antibody-mediated rejection (ABMR), and while the ptc score is incorporated in current diagnostic recommendations, the…
  • 2016 American Transplant Congress

    Donor-Specific Antibody Is a Major Independent Predictor of Accelerated Heart Allograft Vasculopathy (CAV).

    M. Bories,1 S. Varnous,2 C. Lefaucheur,3 P. Rouvier,2 R. Guillemain,1 P. Bruneval,1 J. Duong Van Huyen,4 A. Loupy.4

    1European Georges Pompidou Hospital, Paris, France; 2La Pitié Salpêtrière Hospital, Paris, France; 3Saint-Louis Hospital, Paris, France; 4Necker Hospital, Paris, France.

    Introduction The role of circulating DSA in addition to traditional cardiovascular risk factors, in the development of accelerated CAV have not been demonstrated. We investigated…
  • 2016 American Transplant Congress

    A Virtual Crossmatch Algorithm That Mimics the Sensitivity of Flow Cytometric Crossmatch.

    P. Rao, D. Deo, C. Rhodes, D. King, P. Bowe, J. Napoleon, I. Okere.

    NJ Sharing Network, New Providence, NJ.

    Aim: The new Kidney Allocation System has increased requests for virtual crossmatches (VXM) to predict the possibility of a negative donor specific crossmatch. This study…
  • 2016 American Transplant Congress

    Long-Term Follow-Up of Renal Transplant Recipients (RTR) Treated with IVIG for De Novo Donor Specific Antibodies (DSA).

    R. Knight,1 S. Patel,1 J. Loucks-DeVos,2 S. Kuten,1 A. Gaber.1

    1Houston Methodist Hospital, Houston, TX; 2Kansas University Medical Center, Kansas City, KS.

    Intravenous immune globulin (IVIG) may be beneficial for pre-emptive treatment of de novo DSA in RTR without biopsy-proven acute rejection (AR). Herein, we present long-term…
  • 2016 American Transplant Congress

    Impact of Early Red Blood Cell Transfusion After Kidney Transplantation on De Novo HLA Sensitization in the Setting of Antithymocyte Globulin Induction.

    T. Jouve,1,2 G. Rigault,1,2 B. Janbon,1 R. Tetaz,1 N. Terrier,1 D. Masson,3 L. Rostaing,1,2 P. Malvezzi.1

    1Nephrology and Kidney Transplantation Unit, Grenoble University Hospital, Grenoble, France, Metropolitan; 2Grenoble Alpes University, Grenoble, France, Metropolitan; 3Etablissement Francais du Sang, Grenoble, France, Metropolitan.

    Introduction:HLA specific antibodies detection (HSA) and that of Donor Specific Antibodies (DSA) were revolutionized by the introduction of solid phase assays (Luminex®), therefore making these…
  • 2016 American Transplant Congress

    Kidney Transplantation with Strong Preformed Donor-Specific Antibodies: Impact of C1q-Binding Ability.

    J. Malheiro,1 S. Tafulo,2 S. Santos,1 M. Costa,1 L. Martins,1 L. Dias,1 A. Henriques.1

    1Nephrology, CHP, Porto, Portugal; 2CSTP, Porto, Portugal.

    HLA-incompatible kidney transplantation is associated with worse outcomes given the presence of donor-specific anti-HLA antibodies (DSA). Our aim was to investigate the association between preformed…
  • 2016 American Transplant Congress

    Impact of the New Kidney Allocation System (KAS) on Transplant Rates & Outcomes in Broadly-HLA Sensitized (HS) Patients Transplanted After Desensitization (DES).

    A. Vo,1 X. Zhang,2 S. Williamson,1 K. Myers,1 N. Reinsmoen,2 J. Choi,1 J. Kahwaji,1 A. Peng,1 R. Villicana,1 S. Jordan.1

    1Kidney Transplant, Cedars-Sinai Medical Center, LA, CA; 2HLA Laboratory, Cedars-Sinai Medical Center, LA, CA.

    Introduction: HS patients not desensitized (DES) receiving transplants are at risk for ABMR. DES improves transplant rates, but is limited to donor availability. Implementation of…
  • 2016 American Transplant Congress

    Fc Receptor Binding Assay for Functional Assessment of HLA Antibodies: Initial Clinical Validation.

    E. Woodle, A. Girnita.

    U of Cincinnati, Cincinnati.

    Functional assessment of HLA antibodies (Abs) has historically been limited to complement-based assays, which have known limitations. Moreover, HLA Abs mediate injury by complement-independent mechanisms,…
  • 2016 American Transplant Congress

    Complex Constellation of HLA Antibodies Contributes to Decreasing Trend of Transplant Rate in Candidates with 100% CPRA.

    R. Rajalingam, D. Hyon Gae, D. Kopchaliiska, O. Buenaventura, K. Cunniffe, G. Da Gente, J. Roberts.

    Immunogenetics and Transplantation Laboratory; Department of Surgery, University of California-San Francisco, San Francisco, CA.

    The key component of new KAS is offering an increased priority for sensitized candidates. While transplants (tx) have increased six-fold for recipients with a CPRA…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 47
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences